Researchers at the University of Missouri School of Medicine, in Columbia, are teaming up with the Clinical Research Center for a study to evaluate the safety and effectiveness of a COVID-19 vaccine for children.
The study, according to Eric Maze from M-U, will include children ages 6-months 12-years-old…an age group which is considered by some medical experts as a key to bringing the pandemic to an end.
The study will run for 14 months and include phone calls, telemedicine visits and up to seven in-person visits to the clinical research center at the University.
At the current time, children from 6-months to 6-years-old are needed for the study.
More information about the study can be found online at http://KidCOVEStudy.com.